Abstract
Eukaryotic cell proliferation in metazoans is regulated by a variety of positive and negative signals that serve to rigidly control cell division. This underscores a major problem facing multicellular organisms: namely, how to allow the rapid proliferation of component cells and at the same time never allow those component cells to engage in competition with each other. In principle, any cell that acquires a growth advantage through mutation should out-compete its siblings and generate a hyperplastic clone from which ever more rapidly proliferating mutants are likely to arise. Such an event is, however, extremely rare as demonstrated by the fact that cancer arises in only one in three individuals during the entire course of their lives. Part of the answer to this paradox appears to reside in the multifunctional nature of the components that mediate cell proliferation. One of these, c-Myc, is the subject of this paper.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
C.A. Spencer and M. Groudine, Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res. 56: 1–48 (1991)
G. Evan and T. Littlewood, The role of c-myc in cell growth. Curr. Opin. Genet. & Dev. 3:44–49(1993)
J.M. Almendral, D. Sommer, H. MacDonald-Bravo, J. Burckhardt, J. Perera and R. Bravo, Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol Cell Biol. 8: 2140–2148 (1988)
K. Kelly, B.H. Cochran, C.D. Stiles and P. Leder, Cell specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell. 35: 603–610 (1983)
H. Persson, L. Hennighausen, R. Taub, W. DeGrado and P. Leder, Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation. Science. 225: 687–693 (1984)
G. Ramsay, G.I. Evan and J.M. Bishop, The protein encoded by the human protooncogene c-myc. Proc. Natl Acad. Sci. USA. 81: 7742–7746 (1984)
S.R. Hann and R.N. Eisenman, Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4: 2486–2497 (1984)
G.I. Evan and D.C. Hancock, Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins. Cell. 43: 253–261 (1985)
E.M. Blackwood and R.N. Eisenman, Max. a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science. 251: 1211–7 (1991)
T.K. Blackwell, L. Kretzner, E.M. Blackwood, R.N. Eisenman and H. Weintraub, Sequence-specific DNA binding by the c-Myc protein. Science. 250: 1149–51 (1990)
G.C. Prendergast, D. Lawe and E.B. Ziff, Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell. 65: 395–407 (1991)
G.C. Prendergast and E.B. Ziff, Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science. 251: 186–9 (1991)
T. Littlewood, B. Amati, H. Land and G. Evan, Max and c-Myc/Max DNA binding activities in cell extracts. Oncogene. 7: 1783–1792 (1992)
E.M. Blackwood, B. Luscher and R.N. Eisenman, Myc and Max associate in vivo. Genes Dev. 6: 71–80(1992)
B. Amati, S. Dalton, M. Brooks, T. Littlewood, G. Evan and H. Land, Transcriptional activation by c-Myc oncoprotein in yeast requires interaction with Max. Nature. 359: 423–426(1992)
L. Kretzner, E. Blackwood and R. Eisenman, Myc and Max possess distinct transcriptional activities. Nature. 359: 426–429 (1992)
B. Amati, M. Brooks, N. Levy, T. Littlewood, G. Evan and H. Land, Oncogenic activity of the c-Myc protein requires dimerisation with Max. Cell. 72: 233–245 (1993)
G.J. Kato, J. Barrett, G.M. Villa and C.V. Dang, An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol. 10: 5914–20 (1990)
G.J. Kato, W.M. Lee, L.L. Chen and C.V. Dang, Max. functional domains and interaction with c-Myc. Genes Dev. 6: 81–92 (1992)
J.P. Moore, D.C. Hancock, T.D. Littlewood and G.I. Evan, A sensitive and quantitative enzyme-linked immunosorbence assay for the c-myc and N-myc oncoproteins. Oncogene Res. 2: 65–80(1987)
C.B. Thompson, P.B. Challoner, P.E. Neiman and M. Groudine, Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature. 314: 363–366 (1985)
C. Waters, T. Littlewood, D. Hancock, J. Moore and G. Evan, c-myc protein expression in untransformed fibroblasts. Oncogene. 6: 101–109 (1991)
S.R. Hann, C.B. Thompson and R.N. Eisenman, C-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature. 314: 366–369 (1985)
M. Dean, R.A. Levine, W. Ran, M.S. Kindy, G.E. Sonenshein and J. Campisi, Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J. Biol. Chem. 261: 9161–6 (1986)
A.B. Pardee, Gl events and regulation of cell proliferation. Science. 246: 603–608 (1989)
G. Evan, A. Wyllie, C. Gilbert, T. Littlewood, H. Land, M. Brooks, C. Waters, L. Penn and D. Hancock, Induction of apoptosis in fibroblasts by c-myc protein. Cell. 63: 119–125(1992)
M. Eilers, D. Picard, K.R. Yamamoto and M.J. Bishop, Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature. 340: 66–68(1989)
M. Eilers, S. Schirm and J M. Bishop, The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 10: 133–41 (1991)
J. Stone, T. de Lange, G. Ramsay, E. Jakobvits, J.M. Bishop, H. Varmus and W. Lee, Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell Biol. 7: 1697–1709 (1987)
B. Amati, T. Littlewood, G. Evan and H. Land, The c-Myc protein induces cell cycle progression and apoptosis through dimerisation with Max. Submitted. (1993)
V. Quarmby, W. Beekman, E. Wilson and F. French, Androgen regulation of c-myc messenger ribonucleic acid levels in rat ventral prostate. Mol Endocrinol. 1: 865–874 (1987)
R. Buttyan, Z. Zakeri, R. Lockshin and D. Wolgemuth, Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland. Mol Endocrinol. 2: 650–7 (1988)
N. Kyprianou, H.F. English, N.E. Davidson and J.T. Isaacs, Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 51: 162–6(1991)
J.S. Riegel, E.R. Richie and J.P. Allison, Nuclear events after activation of CD4+8+ thymocytes. J Immunol. 144: 3611–8 (1990)
Y. Shi, J. Glynn, L. Guilbert, T. Cotter, R. Bissonette and D. Green, Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science. 257: 212–214 (1992)
J. Cohen, Overview: Mechanisms of apoptosis. Immunol Today. 14: 126–130 (1993)
N. Touchette, Dying cells reveal new role for cancer genes. J. NIH Research. 4: 48–52 (1992)
R. Baserga, The double life of the IGF-1 receptor. Receptor. 2: 261–6 (1992)
A. Fanidi, E. Harrington and G. Evan, Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature. 359: 554–556 (1992)
A. Strasser, A.W. Harris, ML. Bath and S. Cory, Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 348: 331–3 (1990)
G. Klein, Comparative action of myc and bcl-2 in B-cell malignancy. Cancer Cells. 3: 141–3(1991)
T.J. McDonnell, N. Deane, FM. Platt, G. Nunez, U. Jaeger, J P. McKearn and S.J. Korsmeyer, bcl -2 -immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 57: 79–88 (1989)
G. Nunez, L. London, D. Hockenbery, M. Alexander, J.P. McKearn and S.J. Korsmeyer, Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol. 144: 3602–10 (1990)
D.L. Vaux, S. Cory and J.M. Adams, bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335: 440–2 (1988)
D. Hockenbery, G. Nunez, C. Milliman, R.D. Schreiber and S.J. Korsmeyer, Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348: 334–336(1990)
C.L. Sentman, J.R. Shutter, D. Hockenbery, O. Kanagawa and S.J. Korsmeyer, bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67: 879–88(1991)
A. Strasser, A.W. Harris and S. Cory, bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67: 889–99 (1991)
R. Bissonnette, F. Echeverri, A. Mahboubi and D. Green. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 359: 552–554 (1992)
A.J. Wagner, M.B. Small and N. Hay, Myc-mediated apoptosis is blocked by ectopic expression of bcl-2. Mol Cell Biol 13: 2432–2440 (1993)
T. Miyashita and J.C. Reed, bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res. 52: 5407–11 (1992)
J.C. Reed, S. Haldar, C.M. Croce and M.P. Cuddy, Complementation by BCL2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblasts. Mol Cell Biol. 10:4370–4(1990)
M. van Lohuizen, S. Verbeek, B. Scheijen, E. Wientjens, H. van der Gulden and A. Berns, Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell. 65: 737–52 (1991)
M. van Lohuizen, M. Frasch, E. Wientjens and A. Berns, Sequence similarity between the mammalian bmi-1 proto-oncogene and the Drosophila regulatory genes Psc and Su(z)2. Nature. 353: 353–5 (1991)
Y. Haupt, W.S. Alexander, G. Barri, S.P. Klinken and J.M. Adams, Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell. 65: 753–63 (1991)
S. Verbeek, M. van Lohuizen, M. van der Valk, J. Domen, G Kraal and A. Berns, Mice bearing the E mu-myc and E mu-pim- 1 transgenes develop pre-B-cell leukemia prenatally. Mol Cell Biol. 11:1176–9 (1991)
J.M. Adams and S. Cory, Transgenic models for haemopoietic malignancies. Biochim Biophys Acta. 1072: 9–31 (1991)
M.C. Raff, Social controls on cell survival and cell death. Nature. 356: 397–400 (1992)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Evan, G., Littlewood, T., Hancock, D., Bennett, M., Harrington, E., Fanidi, A. (1994). C-MYC: Oncogene and Tumour Suppressor Gene. In: Mihich, E., Schimke, R.T. (eds) Apoptosis. Pezcoller Foundation Symposia, vol 5. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9217-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9217-1_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9219-5
Online ISBN: 978-1-4757-9217-1
eBook Packages: Springer Book Archive